Researchers at the Johns Hopkins University School of Medicine have discovered how a whole class of commonly used chemotherapy drugs can block cancer growth. Their findings, recently reported online at the Proceedings of the National Academy of Sciences Early Edition, suggest that a subgroup of cancer patients might particularly benefit from these drugs. The anthracycline class of chemotherapeutics have been used for four decades to treat many types of cancer, including leukemia and lymphoma. (source: hopkinsmedicine.org)
|
